Bulletin
Investor Alert

Atea Pharmaceuticals Inc.

NAS: AVIR

GO
/marketstate/country/us

After Hours

/zigman2/quotes/222210381/composite

$

6.48

Change

+0.04 +0.62%

Volume

Volume 464,704

Jan 21, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/222210381/composite

Previous close

$ 6.92

$ 6.44

Change

-0.48 -6.94%

Day low

Day high

$6.44

$6.92

Open
Open: 6.81

52 week low

52 week high

$6.44

$94.17

Open

Market cap

$535.18M

Average volume

1.93M

P/E ratio

23.65

Rev. per Employee

$5.33M

EPS

0.27

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/avir

MarketWatch News on AVIR

  1. Here Are 8 Biotech Stocks That Trade for Less Than Their Cash

    8:28 a.m. Dec. 28, 2021

    - Barron's Online

  2. Pfizer's Covid Antiviral Shows Stunning Efficacy

    10:46 p.m. Nov. 5, 2021

    - Barron's Online

  3. Atea Pharmaceuticals stock price target cut to $16 from $61 at J.P. Morgan

    6:56 a.m. Oct. 20, 2021

    - Tomi Kilgore

  4. Atea Pharmaceuticals downgraded to neutral from overweight at J.P. Morgan

    6:55 a.m. Oct. 20, 2021

    - Tomi Kilgore

  5. Why Facebook May Be Changing Its Name

    10:42 a.m. Oct. 20, 2021

    - Barron's Online

  6. Stocks Closed Up Today. Profits Are a Beautiful Thing.

    4:30 p.m. Oct. 19, 2021

    - Barron's Online

  7. Don't Count Out Covid-19 Monoclonal Antibody Treatments

    10:33 a.m. Oct. 15, 2021

    - Barron's Online

  8. FDA Will Consider Regeneron's Covid-19 Antibody for Full Approval

    9:39 a.m. Oct. 14, 2021

    - Barron's Online

  9. Merck Submits Covid Pill to FDA for Emergency Approval

    9:11 a.m. Oct. 11, 2021

    - Barron's Online

  10. Dice Therapeutics and Hemisphere Media See Activist Action

    8:30 p.m. Oct. 1, 2021

    - Barron's Online

  11. Merck Says Pill Cuts Covid Hospitalization by 50%

    3:41 p.m. Oct. 1, 2021

    - Barron's Online

  12. Merck: Covid-19 Pill Looks Good Against Variants

    3:36 p.m. Sept. 29, 2021

    - Barron's Online

  13. The Stock Market Is Tanking. These 5 Stocks Are Not.

    12:23 p.m. Sept. 20, 2021

    - Barron's Online

  14. Loading more headlines...
/news/nonmarketwatch/company/us/avir

Other News on AVIR

  1. Atea Pharma highlights strategic priorities for 2022

    7:22 a.m. Jan. 7, 2022

    - Seeking Alpha

  2. TDOC, VXRT and CDOX among pre market gainers

    8:25 a.m. Nov. 26, 2021

    - Seeking Alpha

  3. Atea Pharmaceuticals files for $200M mixed shelf offering

    4:29 p.m. Nov. 24, 2021

    - Seeking Alpha

  4. Atea Pharmaceuticals - Boom and Bust in Biotechland

    5:28 p.m. Nov. 23, 2021

    - GuruFocus.com

  5. Warning: AVIR is at high risk of performing badly

    5:35 a.m. Nov. 19, 2021

    - Seeking Alpha

  6. SAVA, CEI and EYES among mid-day movers

    12:39 p.m. Nov. 17, 2021

    - Seeking Alpha

  7. Rivian Automotive, DLocal, StoneCo among premarket losers' pack

    8:36 a.m. Nov. 17, 2021

    - Seeking Alpha

  8. Why Atea Pharmaceuticals Stock Is Sinking Today

    8:13 a.m. Nov. 17, 2021

    - Motley Fool

  9. Loading more headlines...
/news/pressrelease/company/us/avir

Press Releases on AVIR

  1. Atea Pharmaceuticals Highlights Strategic Priorities for 2022

    7:00 a.m. Jan. 7, 2022

    - GlobeNewswire

  2. Atea Pharmaceuticals Added to the Nasdaq Biotechnology Index

    7:00 a.m. Dec. 17, 2021

    - GlobeNewswire

  3. Atea Plummets on Phase Test Data

    9:27 a.m. Oct. 19, 2021

    - Baystreet.ca

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.